The newly approved SGLT2 inhibitor, bexagliflozin, is marketed under the name Brenzavvy. It is not recommended for patients with type 1 diabetes. 

Would residency directors do better to favor high-achieving students from schools of more modest national status?

Early mortality specifically related to complications during the TLR procedure was quite rare. 

"The singular message to the public is that the optimal treatment for multivessel coronary artery disease—to improve not only long-term survival but also lower your risk of complications—is coronary artery bypass surgery," one specialist said in a statement. 

Even if symptoms disappear quickly, a transient ischemic attack can be a major short-term risk indicator.

The FDA has declined to accelerate approval of Eli Lilly’s highly anticipated Alzheimer’s drug, but the reason for the rejection may presage a forthcoming thumbs-up.

A team of cardiologists and cardiac surgeons collaborated on the new analysis, reviewing data from more than 50,000 patients and developing a new risk model for clinicians.  

The Great Resignation hit the healthcare industry by storm during the COVID-19 pandemic, but turnover among CEOs slowed to its lowest level in five years toward the end of 2022.